These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27052127)

  • 1. Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis.
    Bos AC; Tiddens HA; Tong Minh K; Heeres I; Overweel-Uijterlinde JL; Kok AE; Andrinopoulou ER; Janssens HM
    J Cyst Fibros; 2016 Sep; 15(5):645-51. PubMed ID: 27052127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis.
    McCormack P; McNamara PS; Southern KW
    J Cyst Fibros; 2011 Sep; 10(5):343-9. PubMed ID: 21620782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial.
    Dentice RL; Elkins MR; Dwyer GM; Bye PTP
    BMC Pulm Med; 2018 Jan; 18(1):3. PubMed ID: 29310638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Paediatr Respir Rev; 2013 Jun; 14(2):98-9. PubMed ID: 23583049
    [No Abstract]   [Full Text] [Related]  

  • 7. Lung function in adult patients with cystic fibrosis after using the eFlow rapid for one year.
    Naehrig S; Lang S; Schiffl H; Huber RM; Fischer R
    Eur J Med Res; 2011 Feb; 16(2):63-6. PubMed ID: 21463983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients.
    Govoni M; Poli G; Acerbi D; Santoro D; Cicirello H; Annoni O; Ružička J
    Pulm Pharmacol Ther; 2013 Apr; 26(2):249-55. PubMed ID: 23232039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects.
    Lenney W; Edenborough F; Kho P; Kovarik JM
    J Cyst Fibros; 2011 Jan; 10(1):9-14. PubMed ID: 20884302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ; Bos AC; Touw DJ; Tiddens HA; Heijerman HG; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):273-80. PubMed ID: 26716357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS.
    Sands D; Sapiejka E; Gąszczyk G; Mazurek H;
    J Cyst Fibros; 2014 Dec; 13(6):653-60. PubMed ID: 24836961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled therapies for cystic fibrosis].
    Lahzami S; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled antibiotics: dry or wet?
    Tiddens HA; Bos AC; Mouton JW; Devadason S; Janssens HM
    Eur Respir J; 2014 Nov; 44(5):1308-18. PubMed ID: 25323242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    Clavel A; Boulaméry A; Bosdure E; Luc C; Lanteaume A; Gorincour G; Stremler-Lebel N; Sarles J; Andrieu V; Dubus JC
    J Cyst Fibros; 2007 Apr; 6(2):137-43. PubMed ID: 16839826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH; O'Doherty MJ; Graham A; Page CJ; Blower P; Geddes DM; Nunan TO
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis.
    Iles R; Legh-Smith J; Drummond M; Prevost A; Vowler S
    J Cyst Fibros; 2003 Sep; 2(3):120-8. PubMed ID: 15463860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
    Newman SP; Woodman G; Clarke SW
    Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial.
    Dentice RL; Elkins MR; Verschuer J; Eberl S; Dwyer G; Bye PTP
    BMC Pulm Med; 2019 Jul; 19(1):128. PubMed ID: 31311524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebuliser therapy.
    Esmond G
    Prof Nurse; 1998 Oct; 14(1):39-43. PubMed ID: 9866617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.